These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 21048707)
21. Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS. Yamazaki A; Kumagai Y; Yamane N; Tozuka Z; Sugiyama Y; Fujita T; Yokota S; Maeda M J Clin Pharm Ther; 2010 Apr; 35(2):169-75. PubMed ID: 20456735 [TBL] [Abstract][Full Text] [Related]
22. Metabolic changes of acetaminophen after intravenous administration to rats pretreated with a hepatoprotective agent, YH-439. Cho E; Jang SH; Lee JW; Kim ND; Lee MG Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):3-16. PubMed ID: 8824927 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of accelerator mass spectrometry in a human mass balance and pharmacokinetic study-experience with 14C-labeled (R)-6-[amino(4- chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1- methyl-2(1H)-quinolinone (R115777), a farnesyl transferase inhibitor. Garner RC; Goris I; Laenen AA; Vanhoutte E; Meuldermans W; Gregory S; Garner JV; Leong D; Whattam M; Calam A; Snel CA Drug Metab Dispos; 2002 Jul; 30(7):823-30. PubMed ID: 12065441 [TBL] [Abstract][Full Text] [Related]
24. Accelerator mass spectrometry of small biological samples. Salehpour M; Forsgard N; Possnert G Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3928-34. PubMed ID: 18980253 [TBL] [Abstract][Full Text] [Related]
25. Disposition of acetaminophen at 4, 6, and 8 g/day for 3 days in healthy young adults. Gelotte CK; Auiler JF; Lynch JM; Temple AR; Slattery JT Clin Pharmacol Ther; 2007 Jun; 81(6):840-8. PubMed ID: 17377528 [TBL] [Abstract][Full Text] [Related]
26. Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivo. Chen J; Garner RC; Lee LS; Seymour M; Fuchs EJ; Hubbard WC; Parsons TL; Pakes GE; Fletcher CV; Flexner C Clin Pharmacol Ther; 2010 Dec; 88(6):796-800. PubMed ID: 20981003 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic investigation of imatinib using accelerator mass spectrometry in patients with chronic myeloid leukemia. Boddy AV; Sludden J; Griffin MJ; Garner C; Kendrick J; Mistry P; Dutreix C; Newell DR; O'Brien SG Clin Cancer Res; 2007 Jul; 13(14):4164-9. PubMed ID: 17634544 [TBL] [Abstract][Full Text] [Related]
28. Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans. Vyas KP; Halpin RA; Geer LA; Ellis JD; Liu L; Cheng H; Chavez-Eng C; Matuszewski BK; Varga SL; Guiblin AR; Rogers JD Drug Metab Dispos; 2000 Jan; 28(1):89-95. PubMed ID: 10611145 [TBL] [Abstract][Full Text] [Related]
29. A safer method for studying hormone metabolism in an Asian elephant (Elephas maximus): accelerator mass spectrometry. Yon L; Faulkner B; Kanchanapangka S; Chaiyabutr N; Meepan S; Lasley B Zoo Biol; 2010; 29(6):760-6. PubMed ID: 20127658 [TBL] [Abstract][Full Text] [Related]
30. Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge. Ings RM Bioanalysis; 2009 Oct; 1(7):1293-305. PubMed ID: 21083052 [TBL] [Abstract][Full Text] [Related]
31. Probenecid impairment of acetaminophen and lorazepam clearance: direct inhibition of ether glucuronide formation. Abernethy DR; Greenblatt DJ; Ameer B; Shader RI J Pharmacol Exp Ther; 1985 Aug; 234(2):345-9. PubMed ID: 4020675 [TBL] [Abstract][Full Text] [Related]
32. Glucuronidation and biliary excretion of acetaminophen in rats. Hjelle JJ; Klaassen CD J Pharmacol Exp Ther; 1984 Feb; 228(2):407-13. PubMed ID: 6694118 [TBL] [Abstract][Full Text] [Related]
33. Suppression of acetaminophen conjugation and of conjugate elimination in the rat by metyrapone, a classical P-450 inhibitor. Galinsky RE; Corcoran GB Drug Metab Dispos; 1988; 16(3):348-54. PubMed ID: 2900724 [TBL] [Abstract][Full Text] [Related]
34. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [TBL] [Abstract][Full Text] [Related]
35. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers. Vaughan D; Speed J; Medve R; Andrews JS Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420 [TBL] [Abstract][Full Text] [Related]
36. Accelerator mass spectrometry for biomedical research. Brown K; Dingley KH; Turteltaub KW Methods Enzymol; 2005; 402():423-43. PubMed ID: 16401518 [TBL] [Abstract][Full Text] [Related]
37. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation. Rickert DE; Dingley K; Ubick E; Dix KJ; Molina L Chem Biol Interact; 2005 Jun; 155(1-2):55-61. PubMed ID: 15893299 [TBL] [Abstract][Full Text] [Related]
38. Effect of prevention of inorganic sulfate depletion on the pharmacokinetics of acetaminophen in rats. Lin JH; Levy G J Pharmacol Exp Ther; 1986 Oct; 239(1):94-8. PubMed ID: 3761200 [TBL] [Abstract][Full Text] [Related]
39. Quantitating isotopic molecular labels with accelerator mass spectrometry. Vogel JS; Love AH Methods Enzymol; 2005; 402():402-22. PubMed ID: 16401517 [TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry. Gordi T; Baillie R; Vuong le T; Abidi S; Dueker S; Vasquez H; Pegis P; Hopper AO; Power GG; Blood AB J Clin Pharmacol; 2014 Sep; 54(9):1031-7. PubMed ID: 24805288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]